超声引导下新型内冷微波天线消融治疗肝癌临床研究

doi:10.3969/j.issn.1672-5069.2012.05.0015

实用肝脏病杂志 ›› 2012, Vol. 15 ›› Issue (5): 417-420.doi: 10.3969/j.issn.1672-5069.2012.05.0015

超声引导下新型内冷微波天线消融治疗肝癌临床研究

何年安, 王文平, 季正标, 黄备建, 李超伦

230001 合肥市安徽医科大学附属省立医院超声科（何年安）;
上海复旦大学附属中山医院超声科（王文平,季正标,黄备建,李超伦）

收稿日期:2011-12-06 出版日期:2012-10-10 发布日期:2017-03-09
通讯作者: 王文平,E-mail:puguang61@126.com
作者简介:何年安男,40岁,医学博士,副主任医师。主要从事肝肿瘤的超声诊断与介入治疗。E-mail: henianan@yahoo.com.cn

Microwave ablation: a new type of internally cooled microwave antenna in the treatment of patients with primary liver cancer

He Nianan, Wang Wenping, Ji Zhenbiao, et al.

Departmetn of Ultrasound,Anhui Provincial Hospital,Affiliated to Anhui Medical University,Hefei 230001,Anhui Province,China

Received:2011-12-06 Online:2012-10-10 Published:2017-03-09
Contact: Wang Wenping,E-mail:puguang61@126.com

摘要/Abstract

摘要： 目的比较新型内冷天线与非内冷天线微波消融治疗肝癌的临床效果。方法在超声引导下,应用新型内冷天线对43例肝细胞癌患者进行微波消融治疗,将术中与术后的并发症、1月后消融灶的残癌率、1年内消融灶的原位复发率及1年后肝内肝细胞癌总的复发率等指标与以往应用非内冷微波天线消融治疗的17例肝细胞癌患者的相应结果进行比较分析。结果与非内冷天线比较,新型内冷天线治疗患者疼痛发生率从90.9%下降到38.5%,无拔针困难和皮肤烫伤并发症,术后出血并发症也明显减少,两组比较,有显著统计学差异（P<0.05）;影像学检查表明,新型内冷天线的微波消融灶较非内冷天线者球体性好,R值更接近1（P<0.01）;新型内冷天线治疗后1月的残癌率（1.9%）及1年内消融部位的原位复发率（5.8%）显著较非内冷天线者（分别为13.6%和22.7%）减低（P<0.05）,而两组术后一年期肝内肝细胞癌总的复发率无显著性差别（P>0.05）。结论与非内冷天线治疗比,新型内冷天线能有效降低肝癌经皮微波消融治疗的术中、术后并发症和原位复发率,更适合肝癌的微波消融治疗。

关键词: 肝细胞癌, 微波消融, 微波天线, 治疗

Abstract: Objective To compare the clinical effects of two different microwave antennas in the treatment of patients with hepatocellular carcinomas（HCCs）. Methods Under the guidance of ultrasonography,forty-three patients with HCC were ablated using the internally-cooled microwave antenna,and 17 patients with HCC were ablated using the non-internally cooded antenna. The therapeutic effects of the two antennas were compared. Results During therapeutic period,the complications（including local pain,the difficulty of drawing out the antenna,bleeding and skin burning） in the internally cooled antenna were fewer than those in the non-internally cooled antenna（P<0.05）;The coagulation necrosis by the internally-cooled antenna took a more round shape（P<0.01）,and the rate of carcinoma-remained in the ablation sites and 12-month recurrence in ablation by internally cooled antenna were obviously lower than in the non-internally cooled antenna（P<0.05）,while the rate of 12-month recurrence in liver in the two groups had no significant difference（P>0.05）. Conclusions Compared with the non-internally cooled microwave antenna,the internally cooled antenna boasts less complications and lower local recurrence for microwave ablation of HCCs.

Key words: Hepatocellular carcinoma, Microwave ablation, Microwave antenna, Therapy

何年安, 王文平, 季正标, 黄备建, 李超伦. 超声引导下新型内冷微波天线消融治疗肝癌临床研究[J]. 实用肝脏病杂志, 2012, 15(5): 417-420.

He Nianan, Wang Wenping, Ji Zhenbiao, et al.. Microwave ablation: a new type of internally cooled microwave antenna in the treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(5): 417-420.

参考文献

[1] Peng Z W,Zhang Y J,Chen M S,et al. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma:long-term results. Eur J Surg Oncol,2010,36（11）:1054-1060.
[2] Hasegawa K, Kokudo N,Shiina S,et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma:Start of a randomized controlled trial（SURF trial）. Hepatol Res,2010,40（8）:851-852.
[3] Martin R C,Scoggins C R,Mcmasters K M. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol,2010,17（1）:171-178.
[4] 杨秉辉,丛文铭,周晓军,等. 原发性肝癌规范化诊治的专家共识. 实用肝脏病杂志,2009（5）:321-328.
[5] Dong B,Liang P,Yu X,et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. Am J Roentgenol,2003,180（6）:1547-1555.
[6] Dodd G R,Soulen M C,Kane R A,et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics,2000,20（1）:9-27.
[7] He NA,Wang WP,Ji ZB,et al. Microwave ablation:An experimental comparative study on internally cooled antenna versus non-internally cooled antenna in liver models. Acad Radiol,2010,17（7）:894-899.
[8] 何年安,王文平,季正标,等. 新型内冷微波天线凝固肝组织的实验研究. 中国医学影像技术,2004,20（3）:365-367.
[9] Kuang M,Lu M D,Xie X Y,et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna experimental and clinical studies. Radiology,2007,242（3）:914-924.
[10] Wang Y,Sun Y,Feng L,et al. Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol,2008,67（2）:357-361.
[11] Ezaki T,Koyanagi N,Yamagata M,et al. Postoperative recurrence of solitary small hepatocellular carcinoma. J Surg Oncol,1996,62（2）:115-122.
[12] 林芷英,汤钊猷,余业勤. 原发性肝癌根治切除后的复发和治疗. 中华外科杂志,1991,29（2）:93-96.
[13] 何年安,王文平,季正标,等. 实时超声造影评价狗肝微波凝固坏死效果的实验研究. 实用肝脏病杂志,2008,11（5）:300-302.
[14] 何年安,王文平,季正标,等. 经皮微波治疗肝癌坏死范围的超声判断. 实用肝脏病杂志,2009,12（5）:362-365.
[15] Horigome H,Nomura T,Saso K,et al. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma:consideration of local recurrence. Am J Gastroenterol,1999,94（7）:1914-1917.

超声引导下新型内冷微波天线消融治疗肝癌临床研究

Microwave ablation: a new type of internally cooled microwave antenna in the treatment of patients with primary liver cancer

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[5]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[6]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[7]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[8]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[9]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[10]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.
[11]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.
[12]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.
[13]	张瑞, 王剑, 陈世耀. 肝硬化门脉高压症并发血栓形成机制和治疗研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 930-933.
[14]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[15]	赵协山, 伍春瑢, 王春峰, 余积洁, 何青. 替诺福韦联合安络化纤丸治疗HBeAg阴性慢性乙型肝炎患者疗效及其血清肝纤维化指标的变化研究*[J]. 实用肝脏病杂志, 2019, 22(5): 644-647.